KIS protects against adverse vascular remodeling by opposing stathmin-mediated VSMC migration in mice. - Wikidata - awgldk - TriplyDB

KIS protects against adverse vascular remodeling by opposing stathmin-mediated VSMC migration in mice.

KIS protects against adverse vascular remodeling by opposing stathmin-mediated VSMC migration in mice.

http://www.wikidata.org/entity/Q36971523

about

Role of T198 modification in the regulation of p27(Kip1) protein stability and function p27kip1 controls cell morphology and motility by regulating microtubule-dependent lipid raft recycling.The protein kinase KIS impacts gene expression during development and fear conditioning in adult mice.MARCKS Signaling Differentially Regulates Vascular Smooth Muscle and Endothelial Cell Proliferation through a KIS-, p27kip1- Dependent Mechanism.Down-regulation of Stathmin Is Required for the Phenotypic Changes and Classical Activation of Macrophages.Expression of kinase interacting with stathmin (KIS, UHMK1) in human brain and lymphoblasts: Effects of schizophrenia and genotype.CATS (FAM64A) abnormal expression reduces clonogenicity of hematopoietic cells.Stathmin: a protein with many tasks. New biomarker and potential target in cancer.Emerging roles for RNA-binding proteins as effectors and regulators of cardiovascular disease.Vascular smooth muscle cell apoptosis promotes transplant arteriosclerosis through inducing the production of SDF-1α.

P2860

Q27349944-83150E24-300D-41CF-A182-BCB3F2A78968 Q30494330-B553424C-869F-4BFF-A03C-8A7B88029F1F Q34399592-9C520DD8-35B4-4C40-95A2-E3F1E3B0646F Q35830288-53D8E31A-1B83-4435-822A-2585FDD28F31 Q35905393-35C240A9-C927-43E3-A1BD-7735BD7EF15E Q37441088-5E04569F-E2BA-4B88-9E43-85C4719C86C0 Q37708807-8A6148CD-731C-4B83-9110-092441B9FFC0 Q37942978-5EF8C745-389E-4953-9919-A9DE1E5FDB88 Q38773475-B709B630-64AB-48D7-8173-9DADEE2DFE0C Q53154105-D95468F9-D2C8-4E57-AA31-C66962372174

P2860

KIS protects against adverse vascular remodeling by opposing stathmin-mediated VSMC migration in mice.

http://www.wikidata.org/entity/Q36971523

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

KIS protects against adverse v ...... diated VSMC migration in mice.

@en

type

label

KIS protects against adverse v ...... diated VSMC migration in mice.

@en

prefLabel

KIS protects against adverse v ...... diated VSMC migration in mice.

@en

P1433

Q36971523-12427489-6AFD-4C95-8FA1-6E11EB8CEFD5

P1476

Q36971523-622FCDB7-A74E-4B0E-83C3-DC22F500BC93

P2093

Q36971523-2B7BE45F-1D50-4FF4-96AB-55D0BF05B9B9

Q36971523-4661959E-DDEA-4526-854F-C1EE66DC692C

Q36971523-8818D654-22A4-4CD0-9576-4F9CE5B15FEC

Q36971523-AA3460C7-E9C0-41C2-B9FC-F657FF14900F

Q36971523-BEA95696-E6ED-4F5C-ADC4-C611D9D25032

Q36971523-E38B6451-2943-4FE8-8CE0-DF8DAFD96704

P2860

Q36971523-02AFC050-A1CB-4FD9-AC41-E736AAA3F27E

Q36971523-086F6035-2CA2-4276-A2C1-A14CA4EB232B

Q36971523-0D12AB28-2B1A-4D23-8D20-0B031BE301F4

Q36971523-1B6AD87F-BA3E-4B98-8407-F71A771B069A

Q36971523-27C527B3-28A9-4F89-8BFD-80923AF14D68

Q36971523-287FA9AA-B31F-4913-9235-4F638A1AA934

Q36971523-2CE75EC9-71CF-46C8-B4E5-58966D7DC04D

Q36971523-42D7FA41-59BB-4D54-B709-A46B4930BF28

Q36971523-4836BD8A-5BCA-4D01-99F6-C96BB3CF3910

Q36971523-55C78A64-C729-479C-813F-C4D046F272CA

P304

Q36971523-87487B5B-661B-4ACC-9899-2D64AFE89234

P31

Q36971523-F2D982F9-05DD-4722-AFF3-2D7CD2F3AECA

P356

Q36971523-D43AD456-0D4B-4E8A-A662-74DAE62DD420

P407

Q36971523-6209CD36-00CE-4D9E-86A0-FE98BE916B99

P433

Q36971523-8BD6A019-0843-42AD-B66D-56D4C49F108E

P478

Q36971523-1E1419B4-C0FB-47B9-9BB5-139F4CC8EE6A

P577

Q36971523-874A7FE4-B972-45E4-AF22-B1594323376B

P698

Q36971523-CE689508-1216-4DF6-A538-695195141E6D

P932

Q36971523-356B2C62-E60D-4425-8EB5-0AD5C60D1AA4

P356

P1433

Journal of Clinical Investigation

P1476

KIS protects against adverse v ...... diated VSMC migration in mice.

@en

P2093

Elizabeth G Nabel

http://www.w3.org/2001/XMLSchema#string

Hong San

http://www.w3.org/2001/XMLSchema#string

Manfred Boehm

http://www.w3.org/2001/XMLSchema#string

Martin F Crook

http://www.w3.org/2001/XMLSchema#string

Michelle Olive

http://www.w3.org/2001/XMLSchema#string

Thomas H Langenickel

http://www.w3.org/2001/XMLSchema#string

P2860

Dissociation of the tubulin-sequestering and microtubule catastrophe-promoting activities of oncoprotein 18/stathmin

Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases

p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2

A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression.

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

Stathmin interaction with a putative kinase and coiled-coil-forming protein domains

CDK inhibitors: positive and negative regulators of G1-phase progression

TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions

Cell-cycle-regulated phosphorylation of oncoprotein 18 on Ser16, Ser25 and Ser38

Multiple phosphorylation of stathmin. Identification of four sites phosphorylated in intact cells and in vitro by cyclic AMP-dependent protein kinase and p34cdc2

P304

3848-3859

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI33206

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P577

2008-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19033656

http://www.w3.org/2001/XMLSchema#string

P932

2582439

http://www.w3.org/2001/XMLSchema#string